Crescent Capital BDC (NASDAQ:CCAP) Given New $20.00 Price Target at Keefe, Bruyette & Woods

Crescent Capital BDC (NASDAQ:CCAP) had its target price boosted by Keefe, Bruyette & Woods from $19.00 to $20.00 in a research note issued to investors on Monday,Benzinga reports. Keefe, Bruyette & Woods currently has an outperform rating on the stock.

A number of other analysts also recently issued reports on CCAP. LADENBURG THALM/SH SH initiated coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 price target on the stock. Bank of America decreased their target price on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, August 15th. Finally, Wells Fargo & Company cut their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Wednesday, August 14th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, Crescent Capital BDC currently has an average rating of “Moderate Buy” and a consensus target price of $19.17.

Crescent Capital BDC Trading Down 0.2 %

Shares of CCAP opened at $19.18 on Monday. The firm has a market cap of $710.81 million, a P/E ratio of 7.52 and a beta of 0.81. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.26 and a quick ratio of 1.26. Crescent Capital BDC has a 1 year low of $15.91 and a 1 year high of $19.63. The company has a 50 day simple moving average of $18.55 and a two-hundred day simple moving average of $18.50.

Crescent Capital BDC Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.42 per share. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07. This represents a $1.68 annualized dividend and a yield of 8.76%. The ex-dividend date of this dividend is Tuesday, December 31st. Crescent Capital BDC’s payout ratio is presently 65.88%.

Institutional Investors Weigh In On Crescent Capital BDC

Institutional investors have recently modified their holdings of the stock. Sun Life Financial Inc. lifted its position in Crescent Capital BDC by 20.7% in the third quarter. Sun Life Financial Inc. now owns 2,226,308 shares of the company’s stock worth $41,187,000 after buying an additional 382,542 shares during the last quarter. Kovitz Investment Group Partners LLC bought a new stake in shares of Crescent Capital BDC during the 3rd quarter worth approximately $4,878,000. International Assets Investment Management LLC purchased a new stake in Crescent Capital BDC in the third quarter worth $1,899,000. Millennium Management LLC boosted its stake in shares of Crescent Capital BDC by 31.9% during the second quarter. Millennium Management LLC now owns 268,097 shares of the company’s stock valued at $5,035,000 after purchasing an additional 64,902 shares during the period. Finally, Deerfield Management Company L.P. Series C bought a new position in shares of Crescent Capital BDC in the second quarter worth about $1,021,000. 49.46% of the stock is owned by institutional investors.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.